Markets & trends

Vivify acquires AuNutra Industries ingredient platform

Vivify acquires AuNutra Industries ingredient platform

By Asia Sherman

Vivify Specialty Ingredients, a portfolio company of Gryphon Investors, acquired AuNutra Industries, a supplier of botanical extracts and specialty nutritional ingredients, as the private equity firm continues to expand its presence in the high-growth...

Supplement sector rising, ‘safety needs to evolve with it’

NI+Supplement sector rising, ‘safety needs to evolve with it’

By Asia Sherman

Growing supplement use, novel ingredients, personalized nutrition and digital health advice are challenging safety frameworks in a fragmented global regulatory landscape, prompting greater discussion about the tools needed to foster regulatory coherence.

Whey is expensive, scarce and more important than ever in sport nutrition

Guest article

NI+Whey is expensive, scarce and more important than ever in sport nutrition

By Eric Royer, Global Business Development Executive, GIRACT

For European sports nutrition companies, protein sourcing has become a more serious commercial issue. Whey prices have risen sharply, supply remains tight and manufacturers are having to think harder about where they use whey, which grade they need and...

Sports nutrition is becoming everyday nutrition – Taiwan’s VITABOX

NutraIngredients-Asia Awards 2026

Sports nutrition is becoming everyday nutrition – Taiwan’s VITABOX

By Tingmin Koe

Muscle building is a major feature in sports nutrition products, but as consumer profiles and goals become more varied, award-winning Taiwanese brand VITABOX says non-whey and non-amino acid options like probiotics can cater to more individuals while...

Inside the consumer challenges fueling the omega-3 gap

Inside the consumer challenges fueling the omega-3 gap

By Cassandra Stern

Consumer data shows consumers may already know omega-3s matter. Getting them to understand which omega-3s they need, choose a product or food source and stick with it is proving to be a different challenge.

Market Moves: Supplement industry deals of Q3 2026

NI+Market Moves: Supplement industry deals of Q3 2026

By Asia Sherman

Deal activity across the supplement and wider wellness sector remained brisk in the third quarter of 2026, with strategic buyers and private equity firms placing big bets on premium brands, science-led portfolios and scalable manufacturing platforms.

Gut microbiome needs time to adapt to fibermaxxing, experts warn 

Gut microbiome needs time to adapt to fibermaxxing, experts warn 

By Olivia Haslam

The “fibermaxxing” trend could carry a digestive health caveat, with gut health expert Dr. Megan Rossi warning that rapidly increasing fiber intake may cause bloating and gastrointestinal discomfort as the gut microbiota adapts to a higher supply of...

SANS USA moves to Dallas for 2027

SANS USA moves to Dallas for 2027

By Cassandra Stern

The Sports & Active Nutrition Summit USA (SANS USA) is heading to Dallas in 2027 after two consecutive sold-out editions in San Diego.

Women’s health boom puts science communication under the microscope

Women’s health boom puts science communication under the microscope

By Cassandra Stern

CRN’s upcoming SciComms Connect symposium will highlight how women’s health is attracting more research, investment, and product development, but translating that momentum into credible supplement products and consumer messaging remains challenging.

People on the move: New nutra jobs of summer 2026

NI+People on the move: New nutra jobs of summer 2026

By Asia Sherman

The latest executive moves suggest a nutrition industry entering a more institutionalized and global phase of growth and professionalizing around scale, science and channel expansion.

What is the industry getting wrong? FNIS leaders weigh in

What is the industry getting wrong? FNIS leaders weigh in

By Danielle Masterson

From social media pseudoscience and influencer culture to industry advocacy and trend-chasing, Future Nutra Innovation Summit (FNIS) attendees outlined where they see gaps — and what could change them.

Omega-3 doesn’t have a proof problem. It has an experience problem.

NI+Omega-3 doesn’t have a proof problem. It has an experience problem.

By Afif Ghannoum, CEO, CPG Radar

For twenty years, the omega-3 industry built its case around a single question: Does it work? That case is closed. What nobody built for is what happens after the science wins the argument and the buyer still doesn’t reorder. The data on 2,530...

Report: Microbiome startups push deeper into longevity

Report: Microbiome startups push deeper into longevity

By Cassandra Stern

Advances in microbiome research are opening new opportunities in longevity, but clinical evidence and proprietary data could increasingly distinguish evidence-backed products from those following the healthy-aging trend.